Cureus. 2020 Nov 7;12(11):e11369. doi: 10.7759/cureus.11369.

Mark A Taylor 2nd ¹, Holly Zhou ², David M Dansie ³, Scott Short ¹

Author information

• ¹Department of Surgery, University of Utah, Salt Lake City, USA.
• ²Department of Pathology, University of Utah, Salt Lake City, USA.
• ³Department of Radiology, Primary Children's Hospital, Salt Lake City, USA.

Abstract

The recognition of pulmonary manifestations of inflammatory bowel disease (IBD) is important as these diseases can be confused with infectious etiologies (e.g., tuberculosis or fungal infection) and, as a result, may unnecessarily delay institution of appropriate therapy (e.g., infliximab). Furthermore, they are a source of morbidity that may be overlooked and, like other IBD-related pathologies, are often responsive to treatment with corticosteroids, immunomodulators, or biologic therapies. The purpose of this paper is to describe the cases of six children at a single institution with differing presentations, treatments, and responses to treatment of their IBD-related lung disease to improve recognition of this uncommon process.